2017 Endocrine Fellows Series: Osteoporosis and Metabolic Bone Diseases

The annual Endocrine Fellows Series: Osteoporosis and Metabolic Bone Diseases is a live CME-certified conference of pediatric and adult endocrine fellows held in conjunction with the Santa Fe Bone Symposium (August 4-5, 2017) in Santa Fe, New Mexico on August 2-3, 2017. Faculty members present clinical content that incorporates practice guidelines, newly reported research findings, preclinical research and clinical practice patterns from across the field of bone and calcium disorders. In addition, group discussion sessions provide case-based practical strategies on the diagnosis and treatment of patients with osteoporosis and metabolic bone diseases. In addition to the small group setting, which allows fellows to interact with the expert faculty, one of the unique components of Osteo Fellows is the abstract presentation. Select fellows are given the opportunity to present their research at Osteo Fellows and at the Santa Fe Bone Symposium. For details on the current and future programs, visit endocrine.org/osteofellows.

Target Audience

This continuing medical education activity should be of substantial interest to first, second, or third-year endocrine fellows.

Learning Objectives

Upon completion of this educational activity, participants will be better able to:

  • Discuss state-of-the-art research in osteoporosis and metabolic bone disorders
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of osteoporosis as well as metabolic bone disorders
  • Employ enhanced skills and practice management techniques to improve patient care
  • Interpret the treatment guidelines to provide the proper care to patients
  • Identify causes of low bone mass other than osteoporosis
  • Describe the role of calcium, Vitamin D and exercise in skeletal health
  • Select appropriate lifestyle and nutritional interventions to treat patients with osteoporosis

Additional Information

Target Audience: 
Fellow
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Topic Area: 
Bone and Calciotropic Hormones
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Level 5 (Performance (Does))
Activity summary
Available credit: 
  • 14.00 AMA PRA Category 1 Credits
  • 14.00 CME Certificate of Participation
Course opens: 
01/03/2017
Course expires: 
05/19/2018
Rating: 
5
NM
United States

Program Director
Michael R McClung, MD – Oregon Osteoporosis Center

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Michael R McClung, MD: Consultant and Speaker, Amgen, Merck; Consultant, Lilly; Speaker, GlaxoSmithKline.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Available Credit

  • 14.00 AMA PRA Category 1 Credits
  • 14.00 CME Certificate of Participation

Accreditation Period

Course opens: 
01/03/2017
Course expires: 
05/19/2018